| Annual Total Liabilities (Millions of US $) |
|---|
| Quarterly Total Liabilities (Millions of US $) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| $0.000B | $0.000B | ||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| YS Biopharma (LSB) | China | $0.094B | 0.00 |
| Annual Total Liabilities (Millions of US $) |
|---|
| Quarterly Total Liabilities (Millions of US $) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| $0.000B | $0.000B | ||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| YS Biopharma (LSB) | China | $0.094B | 0.00 |